Clinical trial
Effect of Genetic Variation in the Transporter, OAT3, on the Renal Secretion of Cefotaxime
NCT00187655 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Genetic Variation in the Transporter, OAT3, on the Renal Secretion of Cefotaxime
- Lead sponsor
- University of California, San Francisco
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2004
- Completion date
- December 31, 2013
- Enrollment
- 24 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
focus groups